Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study
瑞戈非尼联合改良吉西他滨-奥沙利铂治疗晚期胆道癌患者。随机Ib/II期BREGO研究
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf080
Blanc, Jean-Frédéric; Bouattour, Mohamed; Gauthier, Ludovic; Deshayes, Emmanuel; Guillemard, Sophie; Touchefeu, Yann; Portales, Fabienne; Borg, Christophe; Harguem, Lobna; Guimbaud, Rosine; Mineur, Laurent; Ychou, Marc; Mazard, Thibault; Assenat, Eric